Immunotherapy
Untracked preview. This is not a tracked Signal Bureau entity — the page is generated on request from live coverage search, is not indexed, and carries no editorial curation. Tracked entities live on the Wire.
Cancer treatment that trains the patient's own immune system to attack tumors.
Coverage of Immunotherapy is rising : 48 signals on the latest tracked day, up 9% from its three-week baseline of 44, across 15 coverage verticals (up from 14 a week ago).
If Immunotherapy matters to your work, coverage is climbing off its baseline — worth a closer-than-usual look this week.
What’s changed
5 of the last 7 tracked days ran below the three-week baseline — a sustained cooling, not a one-day dip.
- Steering the immune response: cancer vaccines and the next era of cancer immunotherapy. · J Immunother Cancer · 2026-11-05
- MSI Dx Analysis System as Companion Diagnostic for KEYTRUDA · Business Wire · 2026-11-10 · usually covers Tech
- Samsung Bioepis' Keytruda biosimilar demonstrates equivalence in global Phase 3 trial · Korea Times News · 2026-11-09 · usually covers Patent IP
- Granzyme B as a predictive biomarker for therapeutic outcomes in non-small cell lung cancer patients undergoing anti-PD-1 therapy · Frontiers Precision Oncology · 2026-11-09 · usually covers Precision Medicine
- Two 70-Year-Olds Will Start the Same $12,272 Keytruda Qlex Cancer Injections. One With Medigap Plan G Will Owe $0 in Coinsurance After the Part B Deductible, While the Other Will Owe 20% With No Annual Cap · 24/7 Wall St. · 2026-11-08 · usually covers other coverage
- Samsung Bioepis Says Keytruda Biosimilar Matches Original in Phase 3 · Seoul Economic Daily · 2026-11-08 · usually covers South Korea
What the reporting says
It shows up alongside Colorectal Cancer (381), Lung Cancer (198), Cancer Cells (124), T Cell (129), FDA (206), Clinical Trial (151), China (141), Clinical Trials (131).
Two steps out: AI (through FDA, 206 shared stories on the weaker link); Drug Administration (through FDA, 206 shared stories on the weaker link); FDA Approved (through FDA, 206 shared stories on the weaker link); Northern Mariana Islands (through FDA, 206 shared stories on the weaker link).
Tracked since Mar 11, with coverage on 160 separate days — concentrated in Oncology and Pubmed Targeted.